InBios International
This role supports the development, registration, and lifecycle management of innovative in vitro diagnostic products for emerging infectious diseases and biothreats. The position involves leading regulatory strategy, preparing FDA and international submissions, and ensuring compliance across product development and commercialization. The ideal candidate will collaborate with cross-functional teams to bring impactful diagnostic solutions to market.
InBios International is a Seattle-based, privately owned company founded in 1996 that designs, develops, and manufactures superior quality immunodiagnostic products for infectious diseases such as Dengue, West Nile, Zika, Chikungunya, COVID-19, and more. The company offers diagnostic tests, contract manufacturing, and assay development services, serving clinical labs globally. InBios is FDA registered, USDA licensed, and ISO 13485:2016 certified, with over 25 diagnostic products on the market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for InBios International.
Regulatory Affairs Specialist
Becton Dickinson (BD)
Director, CDx Regulatory Consultant
Precision Medicine Group
Regulatory Affairs Senior Specialist
Leica Biosystems
Regulatory Affairs Director
Truvian Sciences
Director, CDx Regulatory Consultant
Precision Medicine Group
Regulatory Affairs Associate
Adaptive Biotechnologies